Results 201 to 210 of about 19,597,217 (350)

Physical exercise and adolescent mental toughness: mediating effects of family support and socioeconomic status. [PDF]

Front Psychol
Yuan W, Wang G, Wang Z.
europepmc   +1 more source

The relationship between family support; pain and depression in elderly with arthritis

Psychology, Health & Medicine, 2017
Man Hung, Jerry Bounsanga, M. Voss, A. Crum, Wei Chen, Wendy C. Birmingham   +5 more
semanticscholar   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Self-efficacy and family support in the relationship between stress and readiness for disaster response among nurses: a mediation analysis. [PDF]

BMC Nurs
Hsiao PC, Lee SY, Lin C, Chiou CP, Chiang KJ, Pan HH.   +5 more
europepmc   +1 more source

Extended Family Support Networks of Caribbean Black Adults in the United States

Journal of Family Issues, 2017
R. Taylor, Ivy Forsythe-Brown, K. Lincoln, L. Chatters   +3 more
semanticscholar   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Midwife-led psychosocial counseling with family support on postpartum depression and maternal functioning: a randomized controlled trial. [PDF]

BMC Pregnancy Childbirth
Aghebatbekheir A, Mahmoodi Z, Rahimzadeh M, Zandifar A, Saeieh SE.   +4 more
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Bridging cultural divides: family support and psychological resilience as catalysts for student adaptability in Sino-foreign cooperative education. [PDF]

Front Psychol
Yan Y, Mahdi M, He Y.
europepmc   +1 more source

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

Molecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta, Yang Song, Madeleine Ndahayo, Anirudh Saxena, Theresa Guo, Dylan Z. Kelley, Jessica Gore, Andrew Hennigan, Alexa Anderson, John C. Papadimitriou, Daria A. Gaykalova   +10 more
wiley   +1 more source